Inhibition of Cyclin-dependent Kinase 5 Activity Protects Pancreatic Beta Cells from Glucotoxicity
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes (T2D) and Alzheimer disease are degenerative diseases that may share common pathophysiologic mechanisms. Neuronal dysfunction in Alzheimer patients has been linked to overactivity of the cyclin-dependent kinase 5 (CDK5) and its activator p35. Both of these proteins are expressed in the insulin-producing beta cells of the pancreas. Further, glucose enhances p35 gene expression, promoting the formation of active p35/CDK5 complexes that regulate the expression of the insulin gene. In T2D, chronic elevations of glucose, glucotoxicity, impair beta cell function. We therefore postulated that CDK5 and p35 may be responsible for this beta cell impairment and that inhibition of CDK5 might have a beneficial effect. To test this hypothesis, the pancreatic cell line INS-1 was selected as a known in vitro model of glucotoxicity, and roscovitine (10 mum) was used as a CDK5 inhibitor. Chronic exposure of INS-1 cells to high glucose (20-30 mm) reduced both insulin mRNA levels and the activity of an insulin promoter reporter gene. Inhibition of CDK5 prevented this decrease of insulin gene expression. We used DNA binding (gel shift) assays and Western immunoblots to demonstrate that cellular levels of the transcription factor PDX-1, normally decreased by glucotoxicity, were preserved with CDK5 inhibition, as was the binding of PDX-1 to the insulin promoter. Analyses of nuclear and cytoplasmic PDX-1 protein levels revealed that CDK5 inhibition restores nuclear PDX-1, without affecting its cytoplasmic concentration, suggesting that CDK5 regulates the nuclear/cytoplasm partitioning of PDX-1. Using a Myc-tagged PDX-1 construct, we showed that the translocation of PDX-1 from the nucleus to the cytoplasm during glucotoxic conditions was prevented when CDK5 was inhibited. These studies indicate that CDK5 plays a role in the loss of beta cell function under glucotoxic conditions and that CDK5 inhibitors could have therapeutic value for T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the French genome-wide scan (10), variants in both the HHEX and SLC30A8 genes were implicated in T2D susceptibility.”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [10]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A fourth genome-wide association scan, in French subjects, recently reported independent evidence for a T2D signal in this region (10).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [10]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Across the four T2D scans completed (5, 6, 7, 10), TCF7L2 clearly emerges as the largest association signal.”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [10]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“One of the remaining four loci (HHEX/IDE) represents a strong replication of findings recently reported (10).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [10]
Experimental — accuracy not yet measuredIn the citing paper
“CDK5 has been implicated in the regulation of pancreatic beta cell function, through formation of p35/CDK5 complexes that downregulate insulin expression (11, 12).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [11]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stress-Induced Binding of the Transcription Factor CHOP to a Novel DNA Control Element
Ubeda, M., Wang, X.-Z., Zinszner, H., Wu, I., F. Habener, J., & Ron, D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1479 · Cited by 310
Self-citationLeahy, J. L., Cooper, H. E., Deal, D. A., & Weir, G. C. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112389 · Cited by 292
Evolution of β-Cell Dysfunction in the Male Zucker Diabetic Fatty Rat
Tokuyama, Y., Sturis, J., DePaoli, A. M., Takeda, J., Stoffel, M., Tang, J., Sun, X., Polonsky, K. S., & Bell, G. I. (1995) · Diabetes · doi:10.2337/diab.44.12.1447 · Cited by 281
Cdk5 deregulation in the pathogenesis of Alzheimer's disease
Cruz, J. C., & Tsai, L.-H. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.07.001 · Cited by 258
Role of Oxidative Stress in Pancreatic β-Cell Dysfunction
Kajimoto, Y., & Kaneto, H. (2004) · Mitochondrial Pathogenesis · doi:10.1007/978-3-662-41088-2_17 · Cited by 248
Harmon, J. S., Stein, R., & Robertson, R. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410345200 · Cited by 233
Glucotoxicity and β-Cell Failure in Type 2 Diabetes Mellitus
Kaiser, Ν., Leibowitz, G., & Nesher, R. (2003) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2003.16.1.5 · Cited by 210
Kawamori, D., Kajimoto, Y., Kaneto, H., Umayahara, Y., Fujitani, Y., Miyatsuka, T., Watada, H., Leibiger, I. B., Yamasaki, Y., & Hori, M. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2896 · Cited by 209
Role of Oxidative Stress in Pancreatic β‐Cell Dysfunction
KAJIMOTO, Y., & KANETO, H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1293.017 · Cited by 206
Sharma, A. (1995) · Molecular Endocrinology · doi:10.1210/me.9.9.1127 · Cited by 164
Poitout, V, Olson, L. K., & Robertson, R. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118496 · Cited by 158
Olson, L. K., Sharma, A., Peshavaria, M., Wright, C. V., Towle, H. C., Rodertson, R. P., & Stein, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9127 · Cited by 149
Reduced Insulin, GLUT2, and IDX-1 in β-Cells After Partial Pancreatectomy
Zangen, D. H., Bonner-Weir, S., Lee, C. H., Latimer, J. B., Miller, C. P., Habener, J. F., & Weir, G. C. (1997) · Diabetes · doi:10.2337/diab.46.2.258 · Cited by 130
Self-citationLu, M., Seufert, J., & Habener, J. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28349 · Cited by 126
Self-citationCdk5, a therapeutic target for Alzheimer's disease?
Tsai, L., Lee, M.-S., & Cruz, J. C. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.019 · Cited by 123
Seufert, J., Weir, G. C., & Habener, J. F. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2401 · Cited by 121
Self-citationUbeda, M., Kemp, D. M., & Habener, J. F. (2004) · Endocrinology · doi:10.1210/en.2003-1522 · Cited by 80
Self-citationCyclin-Dependent Kinase 5 in Amyotrophic Lateral Sclerosis
Nguyen, M. D., & Julien, J.-P. (2003) · Neurosignals · doi:10.1159/000074623 · Cited by 71
Olson, L. K. (1998) · Molecular Endocrinology · doi:10.1210/me.12.2.207 · Cited by 64
Protective Mechanism of Glucose Against Alloxan-Induced Pancreatic β-Cell Damage
Park, B. H., Rho, H. W., Park, J. W., Cho, C. G., Kim, J. S., Chung, H., & Kim, H. R. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1619 · Cited by 53
Otth, C., Mendoza-Naranjo, A., Mujica, L., Zambrano, A., Concha, I. I., & Maccioni, R. B. (2003) · NeuroReport · doi:10.1097/00001756-200312190-00023 · Cited by 53
Cyclin-dependent kinases in neural development and degeneration
Lim, A. C. B., & Qi, R. Z. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5409 · Cited by 45
Harmon, J. S., Tanaka, Y., Olson, L. K., & Robertson, R. P. (1998) · Diabetes · doi:10.2337/diabetes.47.6.900 · Cited by 43
Up‐regulation of cDK5/p35 by oxidative stress in human neuroblastoma IMR‐32 cells
Strocchi, P., Pession, A., & Dozza, B. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10391 · Cited by 40
The role of pancreatic duodenum homeobox protein-1 in the development of diabetes mellitus
Habener, J. F. (2002) · Drug News & Perspectives · doi:10.1358/dnp.2002.15.8.740224 · Cited by 9
Self-citation
Research works printed but not linked: 3
- Srinivasan, 2002, Am. J. Physiol., 283, E784
- Sharma, 1995, Mol. Endocrinol., 9, 1127
- Olson, 1998, Mol. Endocrinol., 12, 207, 10.1210/mend.12.2.0066 · doi:10.1210/mend.12.2.0066 · Paper page
Cited by
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T., Walters, G. B., Styrkarsdottir, U., Gretarsdottir, S., Emilsson, V., Ghosh, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2043 · Cited by 1,072
“Furthermore, inhibition of the CDK5/p35 complex prevents a decrease of insulin gene expression that results from glucotoxicit”
Background
Metadata
- Authors
- Ubeda, M., Rukstalis, J. M., & Habener, J. F.
- Affiliations
- Harvard University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Habener, Joel F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 281
- Issue
- 39
- Pages
- 28858-28864
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2002427009
- Cited by
- 138
- References
- 25
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 9 · 2020: 3 · 2019: 8 · 2018: 6 · 2017: 10 · 2016: 5 · 2015: 3 · 2014: 8 · 2013: 4 · 2012: 8
- FWCI
- 12.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5152 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057521, DK 55365, R01DK055365, DK057521-06)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- cyclin-dependent kinase 5, p35, glucotoxicity, pancreatic beta cells, type 2 diabetes, insulin gene expression, PDX1, nuclear-cytoplasmic translocation, roscovitine, INS-1 cells, insulin promoter, Alzheimer's disease, CDK5 inhibitors
- MeSH terms
- Animals, Cell Nucleus, Cytoplasm, Diabetes Mellitus, Type 2, Enzyme Inhibitors, Glucose, Insulin, Time Factors, Trans-Activators, Homeodomain Proteins, RNA, Small Interfering, Cell Line, Tumor, Insulin-Secreting Cells, Cyclin-Dependent Kinase 5, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.